We are international
Donate
• IMF TV TEXT SIZE   
webcasts from medical meetings    back

IMF reports from the 2004 annual meeting of the American Society of Hematology in San Diego, California. A special, CME-accredited program, Controversies in Myeloma Management, brought together leading experts to discuss clinical practice issues in the context of patient case studies.

ASH 2004 Controversies In Myeloma Management

CONTROVERSIES IN MYELOMA MANAGEMENT
This CME-certified symposium entitled “Controversies in Myeloma Management: Diagnosis, Initial Treatment, and the Relapsing Patient” was jointly sponsored by the IMF and the Institute for Continuing Healthcare Education, an ACCME-accredited provider of continuing medical education.
12.04.04   CONTROVERSIES IN MYELOMA MANAGEMENT - INTRODUCTION

12.04.04   CURRENT US EXPERIENCE WITH TRANSPLANTION AND MANAGEMENT OF THE NEWLY DIAGNOSED PATIENT

12.04.04   OVERVIEW OF KYPHOPLASTY IN THE MANAGEMENT OF SPINAL TUMORS

12.04.04   EVALUATION OF THE PATIENT IN INITIAL RELAPSE AND SELECTION OF SECOND-LINE THERAPEUTIC OPTIONS

12.04.04   NEW APPROACHES TO MYELOMA STAGING AND FRONT-LINE TREATMENT SELECTION

12.04.04   PRELIMINARY CASE EVALUATION: AN INTERACTIVE ASSESSMENT OF AUDIENCE TREATMENT OPTIONS

12.04.04   SUPPORTIVE CARE AND THE MANAGEMENT OF THE NEWLY DIAGNOSED AND INITIALLY RELAPSING PATIENT

12.04.04   CURRENT EUROPEAN EXPERIENCE WITH TRANSPLANTATION AND MANAGEMENT OF THE NEWLY DIAGNOSED PATIENT